XML 61 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
Note 11 - Share Capital (Tables)
12 Months Ended
Nov. 30, 2021
Statement Line Items [Line Items]  
Disclosure of reserves within equity [text block]
  

Restricted Shares
($)

  

Share Options
($)

  

Warrants
($)

  

Total
($)

 

Balance at November 30, 2019

  8,568   5,588,047   4,343,351   9,939,966 

Options exercised

  -   (2,388,416)  -   (2,388,416)

Restricted share rights vested

  (270,815)  -   -   (270,815)

Warrants exercised

  -   -   (802,566)  (802,566)

Share-based compensation

  288,552   2,335,974   -   2,624,526 

Balance at November 30, 2020

  26,305   5,535,605   3,540,785   9,102,695 

Options exercised

  -   (751,727)  -   (751,727)

Restricted share rights vested

  (105,190)  -   -   (105,190)

Share-based compensation

  116,284   1,744,490   -   1,860,774 

Balance at November 30, 2021

  37,399   6,528,368   3,540,785   10,106,552 
Disclosure of number and weighted average exercise prices of share options [text block]
  

Number of

Options

  

Weighted

Average

Exercise Price

($)

 

Balance at November 30, 2019

  12,463,000   1.15 

Granted

  2,695,000   2.48 

Exercised(1)

  (4,359,750)  1.07 

Expired/Forfeited

  (66,250)  0.80 

Balance at November 30, 2020

  10,732,000   1.51 

Granted

  3,015,000   1.84 

Exercised(2)

  (1,197,850)  1.00 

Expired

  (105,000)  2.50 

Balance at November 30, 2021

  12,444,150   1.63 
Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]
  

November 30,

2021

  

November 30,

2020

 

Risk-free interest rate

  1.03%  0.35%

Expected life (years)

  2.74   2.43 

Expected volatility

  59.80%  59.25%

Expected dividend yield

  0.00%  0.00%

Estimated forfeiture rate

  3.82%  2.45%
Disclosure of range of exercise prices of outstanding share options [text block]
    

Options Outstanding

  

Options Exercisable

 

Exercise

Prices

 

Number of

Options

Outstanding

  

Weighted

Average

Exercise

Price

($)

  

Weighted

Average

Remaining

Contractual

Life

(years)

  

Number of

Options

Exercisable

  

Weighted

Average

Exercise

Price

($)

  

Weighted

Average

Remaining

Contractual

Life

(years)

 

$0.78

-$0.84  1,787,500   0.78   1.99   1,787,500   0.78   1.99 

$0.85

-$1.05  2,224,500   1.05   2.71   2,224,500   1.05   2.71 

$1.06

-$1.72  3,455,000   1.59   0.88   3,380,000   1.59   0.79 

$1.73

-$1.84  2,745,000   1.83   4.81   746,250   1.82   4.45 

$1.85

-$3.38  2,232,150   2.74   3.59   1,640,900   2.76   3.62 
     12,444,150   1.63   2.72   9,779,150   1.53   2.20 
Disclosure of earnings per share [text block]
  

Year ended November 30, 2021

  

Year ended November 30, 2020

 
  

Income for

  

Weighted

  

Income

  

Loss for

  

Weighted

  

Loss

 
  

the period

  

average shares

  

per share

  

the year

  

average shares

  

per share

 
   ($)  

outstanding

   ($)   ($)  

outstanding

   ($) 

Basic income (loss) per share

  100,355,240   149,407,112   0.67   (11,087,643)  146,046,711   (0.08)

Effect of dilutive securities:

                        

Stock options

  -   3,102,078   -   -   -   - 

Diluted income (loss) per share

  100,355,240   152,509,190   0.66   (11,087,643)  146,046,711   (0.08)
Restricted share rights [member]  
Statement Line Items [Line Items]  
Disclosure of number and weighted average exercise prices of other equity instruments [text block]
  

Number of

RSRs

  

Weighted Average Value

($)

 

Balance at November 30, 2019

  207,488   1.05 

Granted

  67,750   2.88 

Vested

  (226,198)  1.20 

Balance at November 30, 2020

  49,040   2.88 

Granted

  50,000   1.83 

Vested

  (36,540)  2.88 

Balance at November 30, 2021

  62,500   2.04